What is UKCA Marking, and why is it required for exporting medical devices from Algeria to Great Britain?

UKCA (UK Conformity Assessed) Marking is the post-Brexit conformity mark required for placing medical devices and IVDs on the market in Great Britain (England, Scotland, and Wales). Algerian manufacturers exporting to the UK must comply with the UK Medical Devices Regulations 2002 (UK MDR 2002), obtain UKCA certification (where applicable), and register their products with the MHRA.

Do medical device manufacturers based in Algeria need a UK Responsible Person (UKRP)?

Yes. Foreign medical device manufacturers based outside the UK (including those in Algeria) must appoint a UK Responsible Person (UKRP). The UKRP acts as the legal liaison between the manufacturer and the MHRA, holding technical documentation and managing post-market surveillance and adverse event reporting in Great Britain.

Can UKCA certification or MHRA registration be used for ANPP product homologation in Algeria?

Yes. Algeria's ANPP (Agence Nationale des Produits Pharmaceutiques) evaluates international reference approvals during technical review. Submitting a product dossier supported by UKCA certification, ISO 13485 accreditation, and an official MHRA registration summary provides strong evidence of safety and quality, helping streamline local homologation.

How does dual CE Marking and UKCA Marking work for MedTech exporters in Algeria?

To maintain commercial access to both the European Union and Great Britain, Algerian manufacturers often adopt a dual CE/UKCA compliance strategy. Operon Strategist harmonizes technical documentation so that a single core technical file satisfies both EU MDR/IVDR requirements for CE Marking and UK MDR 2002 requirements for UKCA Marking.

What technical documentation is required for MHRA device registration under UKCA?

To complete an MHRA device registration, the technical dossier must include: Device Classification & Risk Analysis compliant with UK MDR 2002. ISO 13485 Certification and Quality Management System records. Technical File / STED including verification, validation, and clinical evidence. Declaration of Conformity declaring compliance with UK legislation. UKRP Designation Agreement and local British contact details.

OPERON ELEVATEPLUS | UKCA MARKING FOR MEDICAL DEVICES

UKCA Marking & MHRA Registration for Medical Devices in Algeria

Operon Strategist delivers comprehensive UKCA Marking and MHRA regulatory consulting in Algeria. We assist medical device manufacturers, exporters, and local distributors through UK risk classification, technical file preparation aligned with UK MDR 2002, UK Responsible Person (UKRP) setup, and direct MHRA portal registration—simplifying market access into Great Britain while supporting dual CE/UKCA compliance strategies.

Take the next step

Connect with our experts to discuss your next big medical device idea

Operon ElevatePlus
UKCA Marking for Medical Devices Service Portfolio

UKCA Regulatory Strategy & Classification

Technical Documentation Preparation

MHRA Registration & Application Support

UK Responsible Person (UKRP) Assistance

Conformity Assessment & UK Approved Body Support

Post-Approval Support & Ongoing Compliance

What Sets Us Apart

Global exposure, structured thinking, and execution-ready expertise

UKCA Marking & MHRA Registration Services – We enable medical device and IVD companies operating in Algeria to achieve UK Conformity Assessed (UKCA) compliance. Our end-to-end consulting covers Approved Body conformity assessments, UKRP representation, and technical documentation harmonization—ensuring seamless export to the UK market and providing audit-ready safety data for Algerian ANPP (Agence Nationale des Produits Pharmaceutiques) registration dossiers.

Operon UKCA Marking for Medical Devices Advantage

Complete regulatory support for achieving UKCA (UK Conformity Assessed) compliance and MHRA device registration, enabling market access in Great Britain